MBC-11 (triethylamine)
MBC-11 triethylamine is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC) . MBC-11 triethylamine has the potential for tumor-induced bone disease (TIBD) research[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mbc-11-triethylamine.html
Purity
90.0
Solubility
10 mM in DMSO
Smiles
CCN(CC)CC.CC(P(O)(O)=O)(P(O)(OP(O)(OC[C@@H]1[C@@H](O)[C@H](O)[C@H](N2C=CC(N)=NC2=O)O1)=O)=O)O
Molecular Formula
C17H35N4O14P3
Molecular Weight
612.40
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-107093B/MBC-11-triethylamine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-107093B/
Scientific Category
Reference compound1
Clinical Information
Phase 1
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CDA, ID (CDA, CDD, Cytidine deaminase, Cytidine aminohydrolase) (MaxLight 750)
CDA, ID (CDA, CDD, Cytidine deaminase, Cytidine aminohydrolase) (MaxLight 750)
